知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

118 records (took 0.027 seconds)

    Vaporized Medicants and Methods of Use
    94.
    发明申请
    Vaporized Medicants and Methods of Use 审中-公开
    蒸发药物及使用方法

    公开(公告)号：US20160143974A1

    公开(公告)日：2016-05-26

    申请号：US15008154

    申请日：2016-01-27

    Applicant: Chong Corporation

    Inventor： Alexander Chinhak Chong ,  William P. Bartkowski ,  Marshall A. Thompson

    IPC: A61K36/296 ,  A61K31/7048 ,  A61K9/00 ,  A61K31/475

    CPC classification number: A61K36/296 ,  A61K9/007 ,  A61K31/475 ,  A61K31/485 ,  A61K31/7048 ,  A61K36/34 ,  A61K47/10 ,  A61K47/26 ,  A61K2236/00 ,  Y10S514/958

    Abstract: A method and formulation for delivering a sexual aid, such as epimedium or yohimbe, in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the active compound. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer.

    Abstract translation: 一种用于使用低温将气质化物质（例如淫羊藿或育亨宾）递送至气化状态以蒸发制剂的方法和制剂。 制剂含有惰性非反应性化合物，其降低制剂的蒸发热和活性化合物。 制剂可以任选地含有甘油，醇和/或水。 可以充分降低制剂蒸发热的惰性非反应性化合物的实例包括丙二醇，植物甘油和聚山梨醇酯。 制剂可以使用手持式低温蒸发器或雾化器蒸发。

    Use of icariin and epimedium flavonoids containing icariin to treat diseases associated with myelin sheath lesion
    95.
    发明授权
    Use of icariin and epimedium flavonoids containing icariin to treat diseases associated with myelin sheath lesion 有权
    使用含有淫羊藿苷的淫羊藿苷和淫羊藿黄酮治疗与髓鞘病变相关的疾病

    公开(公告)号：US09050353B2

    公开(公告)日：2015-06-09

    申请号：US13703168

    申请日：2011-06-07

    Applicant: Lin Li ,  Linlin Yin ,  Lili Lin ,  Lan Zhang ,  Wen Wang ,  Ruyi Zhang

    Inventor： Lin Li ,  Linlin Yin ,  Lili Lin ,  Lan Zhang ,  Wen Wang ,  Ruyi Zhang

    IPC: A61K31/7048 ,  A61K36/296

    CPC classification number: A61K31/7048 ,  A61K36/296

    Abstract: New use of icariin and Epimedium flavaoids containing icariin is provided by the present invention. Specifically, uses of compounds of Formula I or Epimedium containing compounds of formula I, Epimedium flavanoids, or extracts of Epimedium in manufacturing medicaments for treating, preventing, reducing and/or relieving diseases and/or conditoins related to neural myelin sheath impairments, or use of above materials in manufacturing medicaments for relieving demyelination and/or promoting repair of myelin sheath are provided by the present application, wherein, R1 is selected from H, halogen, —C1-6 alkyl, and —C(O)—C1-4 alkyl

    Abstract translation: 本发明提供了新的使用含淫羊藿苷和淫羊藿苷的淫羊藿苷。 具体地，在制备用于治疗，预防，减少和/或减轻与神经髓鞘损伤相关的疾病和/或状况的药物中使用式I化合物或含淫羊藿的式I化合物，淫羊藿苷或淫羊藿提取物的用途或用途 在本申请中提供了用于缓解脱髓鞘和/或促进髓鞘的修复的药物的上述材料，其中R 1选自H，卤素，-C 1-6烷基和-C（O）-C1-4 烷基

    NOVEL ANTIOXIDANT FORMULATIONS
    96.
    发明申请
    NOVEL ANTIOXIDANT FORMULATIONS 审中-公开
    新型抗氧化剂配方

    公开(公告)号：US20150147389A1

    公开(公告)日：2015-05-28

    申请号：US14550859

    申请日：2014-11-21

    Applicant: Phillip E. Schoenwetter

    Inventor： Phillip E. Schoenwetter

    IPC: A61K36/296 ,  A61K31/353 ,  A61K31/7048 ,  A61K31/05 ,  A61K31/375 ,  A61K31/385 ,  A61K31/015 ,  A61K31/198 ,  A61K31/355

    CPC classification number: A61K36/296 ,  A61K31/015 ,  A61K31/05 ,  A61K31/198 ,  A61K31/353 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/7048 ,  A61K2300/00

    Abstract: An antioxidant composition comprises one or more amino acids; a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof; and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.

    Abstract translation: 抗氧化剂组合物包含一种或多种氨基酸; 选自染料木素，糖苷配基染料木素，激素受体调节剂，1,2,3型和4型磷酸二酯酶（PDE）抑制剂，抗肿瘤性酪氨酸激酶抑制剂及其组合的染料木素替代物; 和选自icarosides 1或2，PDE-4抑制剂，PDE-5抑制剂，淫羊藿品种的衍生物，包括青蒿琥酯I和II以及它们的组合的淫羊藿苷替代物。

    PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUMBAR DISC HERNIATION AND PREPARATION METHOD THEREOF
    99.
    发明申请
    PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUMBAR DISC HERNIATION AND PREPARATION METHOD THEREOF 失效
    用于治疗腰椎间盘突出症的药物组合物及其制备方法

    公开(公告)号：US20110262568A1

    公开(公告)日：2011-10-27

    申请号：US13091305

    申请日：2011-04-21

    Applicant: Kyoung Sam BYUN

    Inventor： Kyoung Sam BYUN

    IPC: A61K36/8962 ,  A61P19/00

    CPC classification number: A61K36/254 ,  A61K36/21 ,  A61K36/28 ,  A61K36/286 ,  A61K36/296 ,  A61K36/489 ,  A61K36/53 ,  A61K36/8962

    Abstract: Disclosed are a pharmaceutical composition useful for treating lumbar disc herniation and a method for the preparation thereof. Composed of herbal ingredients, the pharmaceutical composition neither incurs resistance nor side effects, even when it is administered for a long term. The composition comprises Acanthopanax senticosus in an amount of 20˜40 wt %, Atractylodis Rhizoma Alba in an amount of 30˜50 wt %, Carthamus tinctorius seed powder in an amount of 3˜10 wt %, Sophora flavescens Aiton in an amount of 5˜15 wt %, Achyranthis Bidentatae Radix in an amount of 1˜5 wt %, Dipsaci Radix in an amount of 1˜5 wt %, pine knars in an amount of 1˜5 wt %, Epimedium Koreanum in an amount of 1˜5 wt %, and Allium tuberosum in an amount of 1˜5 wt %.

    Abstract translation: 公开了用于治疗腰椎间盘突出症的药物组合物及其制备方法。 由草药成分组成，即使长期服用，药物组合物也不会产生抗药性和副作用。 该组合物含有20〜40重量％的刺五加，30〜50重量％的白术（Atractylodis Rhizoma Alba），3〜10重量％的苦参粉末粉末，苦参 〜15重量％，1〜5重量％的白芷，1〜5重量％的Dipsaci Radix，1〜5重量％的松树，，1〜5重量％的淫羊藿， 5重量％，马铃薯葱为1〜5重量％。

Patent Agency Ranking